Wearable Injectors Market By Type (On-Body Injectors and Off-Body Injectors), By Applications (Oncology, Diabetes, Autoimmune Disease, Cardiovascular Disease, and Other Applications), By Technology, By End-User, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032
- Published date: Oct 2024
- Report ID: 101436
- Number of Pages: 287
- Format:
-
keyboard_arrow_up
-
-
- Becton, Dickinson and Company Profile
- Ypsomed
- Amgen
- Insulet Corporation
- Tandem Diabetes Care, Inc.
- Johnson & Johnson Private Limited
- Hoffmann-La Roche AG
- Unilife Corporation
- West Pharmaceuticals Services, Inc.
- Medtronic
- SteadyMed Ltd.
- Other Key Players
- settingsSettings
Our Clients
- 101436
- Oct 2024
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
